Expressing support for the designation of the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day".

Black Americans make up 13 percent of the U.S. population but account for 30 percent of people with kidney failure — and a key genetic factor behind this disparity is the APOL1 gene. An estimated 13 percent of Black Americans carry variants in both copies of this gene, giving them a 1-in-5 chance of developing a rapidly progressive form of kidney disease that can advance to kidney failure with no symptoms until it's nearly too late. This resolution supports designating the last Tuesday of April as APOL1-Mediated Kidney Disease Awareness Day, encourages genetic testing for people with West or Central African ancestry, and highlights the need for more research since there are currently no FDA-approved treatments for this condition.